Literature DB >> 25272301

Differential patterns of PAX8, p16, and ER immunostains in mesonephric lesions and adenocarcinomas of the cervix.

Abha Goyal1, Bin Yang.   

Abstract

Mesonephric remnants, usually located deep in the lateral cervical wall, may become hyperplastic resulting in a florid proliferation. These can be misinterpreted as malignant and confused with endocervical adenocarcinomas. Recent data have shown that PAX2 is diffusely expressed in mesonephric remnants and hyperplasias. PAX8 is a related transcription protein that is expressed in tissues of müllerian and wolffian origin. In this study, we have investigated the utility of an immunohistochemical panel comprising of PAX8, estrogen receptor (ER), and p16 in the differential diagnosis between mesonephric proliferations and cervical adenocarcinomas. A database search was conducted for cases of mesonephric remnants/hyperplasia/carcinoma of cervix and invasive cervical adenocarcinomas. Immunohistochemical stains for PAX8, ER, and p16 were performed using the avidin-biotin peroxidase technique on the most representative tissue. The search yielded 28 cases of mesonephric proliferations of cervix (15 mesonephric remnants, 12 mesonephric hyperplasias, and 1 mesonephric adenocarcinoma) and 16 cases of cervical adenocarcinomas (15 usual type and 1 adenoma malignum). Immunohistochemically, all the mesonephric proliferations, regardless of being benign or malignant, displayed a consistent staining pattern-diffusely and strongly positive for PAX8, negative for ER, and patchy cytoplasmic staining for p16. The usual type cervical adenocarcinomas exhibited a variable staining pattern with PAX8 and ER but all were strongly and diffusely positive for p16. The case of adenoma malignum was PAX8 positive, ER negative, and showed weak and patchy staining with p16. Our study suggests that a panel of immunohistochemical stains composed of PAX8, p16, and ER is useful in the distinction between mesonephric proliferations and cervical adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25272301     DOI: 10.1097/PGP.0000000000000102

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  10 in total

1.  Uterine Paramesonephric Cysts in Sprague-Dawley Rats from National Toxicology Program Studies.

Authors:  Daven N Jackson-Humbles; John Curtis Seely; Ronald A Herbert; David E Malarkey; Barry S McIntyre; Paul M Foster; Darlene Dixon
Journal:  Toxicol Pathol       Date:  2018-04-29       Impact factor: 1.902

2.  Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.

Authors:  Marcela S Cavalcanti; Anne M Schultheis; Caleb Ho; Lu Wang; Deborah F DeLair; Britta Weigelt; Ginger Gardner; Stuart M Lichtman; Meera Hameed; Kay J Park
Journal:  Int J Gynecol Pathol       Date:  2017-01       Impact factor: 2.762

3.  Mesonephric adenocarcinoma of the uterine cervix with rare lung metastases: A case report and review of the literature.

Authors:  Li-Li Jiang; De-Ming Tong; Zi-Yi Feng; Kui-Ran Liu
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

4.  Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases.

Authors:  Jennifer A Bennett; Lauren L Ritterhouse; Larissa V Furtado; Ricardo R Lastra; Anna Pesci; Jordan M Newell; Eike Burandt; Loes Kooreman; Koen Van de Vijver; Thomas Krausz; Ana Felix; Gian Franco Zannoni; Robert H Young; Esther Oliva
Journal:  Mod Pathol       Date:  2019-10-07       Impact factor: 7.842

5.  Cytologic features of upper gynecologic tract adenocarcinomas exhibiting mesonephric-like differentiation.

Authors:  Brie Kezlarian; Stephanie Muller; Vitor Werneck Krauss Silva; Carlene Gonzalez; Daniel J Fix; Kay J Park; Rajmohan Murali
Journal:  Cancer Cytopathol       Date:  2019-07-18       Impact factor: 5.284

6.  Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics.

Authors:  Hyun Hee Koh; Eunhyang Park; Hyun-Soo Kim
Journal:  Diagnostics (Basel)       Date:  2022-01-27

7.  Atypical Mesonephric Hyperplasia of the Uterus Harbors Pathogenic Mutation of Kirsten Rat Sarcoma 2 Viral Oncogene Homolog (KRAS) and Gain of Chromosome 1q.

Authors:  Hyunjin Kim; Nara Yoon; Ha Young Woo; Eui-Jin Lee; Sung-Im DO; Kiyong Na; Hyun-Soo Kim
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

8.  Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases.

Authors:  Edaise M da Silva; Daniel J Fix; Ana Paula Martins Sebastiao; Pier Selenica; Lorenzo Ferrando; Sarah H Kim; Anthe Stylianou; Arnaud Da Cruz Paula; Fresia Pareja; Evan S Smith; Ahmet Zehir; Jason A Konner; Karen Cadoo; Jorge S Reis-Filho; Nadeem R Abu-Rustum; Jennifer J Mueller; Britta Weigelt; Kay J Park
Journal:  Mod Pathol       Date:  2021-03-26       Impact factor: 7.842

Review 9.  Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists.

Authors:  Simona Stolnicu; Kay J Park; Takako Kiyokawa; Esther Oliva; W Glenn McCluggage; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

10.  New Insights in the Diagnosis of Rare Adenocarcinoma Variants of the Cervix-Case Report and Review of Literature.

Authors:  Cristina Secosan; Oana Balint; Aurora Ilian; Lavinia Balan; Ligia Balulescu; Andrei Motoc; Delia Zahoi; Dorin Grigoras; Laurentiu Pirtea
Journal:  Healthcare (Basel)       Date:  2022-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.